User profiles for Paul P. Glasziou
Paul GlasziouCREBP, Bond University, Gold Coast, Australia Verified email at bond.edu.au Cited by 139309 |
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne… - Bmj, 2014 - bmj.com
… Tammy C Hoffmann associate professor of clinical epidemiology1, Paul P Glasziou director
and professor of evidence based medicine1, Isabelle Boutron professor of epidemiology2, …
and professor of evidence based medicine1, Isabelle Boutron professor of epidemiology2, …
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.
Background To comprehend the results of diagnostic accuracy studies, readers must understand
the design, conduct, analysis, and results of such studies. That goal can be achieved …
the design, conduct, analysis, and results of such studies. That goal can be achieved …
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Incomplete reporting has been identified as a major source of avoidable waste in biomedical
research. Essential information is often not provided in study reports, impeding the …
research. Essential information is often not provided in study reports, impeding the …
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration
…, DE Bruns, CA Gatsonis, PP Glasziou… - Annals of internal …, 2003 - acpjournals.org
The quality of reporting of studies of diagnostic accuracy is less than optimal. Complete and
accurate reporting is necessary to enable readers to assess the potential for bias in the …
accurate reporting is necessary to enable readers to assess the potential for bias in the …
[BOOK][B] Decision making in health and medicine: integrating evidence and values
…, MF Drummond, JS Pliskin, JB Wong, PP Glasziou - 2014 - books.google.com
Decision making in health care involves consideration of a complex set of diagnostic,
therapeutic and prognostic uncertainties. Medical therapies have side effects, surgical …
therapeutic and prognostic uncertainties. Medical therapies have side effects, surgical …
Physical interventions to interrupt or reduce the spread of respiratory viruses
…, J Clark, EM Beller, PP Glasziou… - Cochrane database …, 2023 - cochranelibrary.com
Background Viral epidemics or pandemics of acute respiratory infections (ARIs) pose a global
threat. Examples are influenza (H1N1) caused by the H1N1pdm09 virus in 2009, severe …
threat. Examples are influenza (H1N1) caused by the H1N1pdm09 virus in 2009, severe …
Antibiotics for acute otitis media in children
…, SL Sanders, PP Glasziou… - … of systematic reviews, 2023 - cochranelibrary.com
Background Acute otitis media (AOM) is one of the most common diseases in childhood for
which antibiotics are commonly prescribed; a systematic review reported a pooled …
which antibiotics are commonly prescribed; a systematic review reported a pooled …
Screening for colorectal cancer using the faecal occult blood test, Hemoccult
P Hewitson, PP Glasziou, L Irwig… - Cochrane Database …, 2007 - cochranelibrary.com
Background Colorectal cancer is a leading cause of morbidity and mortality, especially in
the Western world. The human and financial costs have prompted considerable research to …
the Western world. The human and financial costs have prompted considerable research to …
Antibiotics for sore throat
C Del Mar, PP Glasziou… - Cochrane Database of …, 2004 - cochranelibrary.com
Background Sore throat is a very common reason for people to seek medical care. It is a
disease that remits spontaneously, that is,'cure'is not dependent on treatment. Nonetheless …
disease that remits spontaneously, that is,'cure'is not dependent on treatment. Nonetheless …
[HTML][HTML] PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts
… “Six studies reported on maternal mortality and our meta-analysis showed a non-significant
reduction (three randomised trials, relative risk 0.79, 0.53 to 1.05, P = 0.12; three non-randomised …
reduction (three randomised trials, relative risk 0.79, 0.53 to 1.05, P = 0.12; three non-randomised …